Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of acupressure plus SNP-based personalized antiemetics in breast cancer chemotherapy
2015-000658-39Phase 2Terminated
- Sponsor
- Region Jönköpings Län
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of betamethasone in nausea ((none)) and breast cancer (2 arms), sponsored by Region Jönköpings Län. Primary endpoint: Patient-reported nausea within 10 days post-chemotherapy. Started Mar 2016; status: terminated.
02
Drugs
betamethasone
03
Conditions
nausea ((none))breast cancer
Beyond the preview
Go deeper on 2015-000658-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000658-39.